CME Group (CME) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
CME Group · Financials · ref. ETF XLF · 74 calls · price $280.94
What the company does: CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide.
📈 CME Group (CME) stock price
$280.94+5.3% over range
Aug 28, 25low $218.58 · high $326.46Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
46% recommend buying · 13 analysts
📊 JPI status : CME Group has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.
🎯 CME price target & analyst consensus — price $281
The price target · all analysts combined (11 targets)
Highest target · 1 firm of 11$330+17.5%
Median target · of 11 targets$270-3.9%
Lowest target · 1 firm of 11$230-18.1%
Current price$280.94
Where these 11 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
545%
$295 ↔ $330
Below
655%
$230 ↔ $270
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Piper Sandler — 71% of its targets hit on this sector (413 calls tested). It aims for $295 (+5.0 %), call made on July 16, 2026, maturing on July 16, 2027 (43 d ago).
The 10 reliable analysts
$270-3.9 %
The 1 other firm
$323+15 %
How to read it: the 10 reliable firms are not filtered by optimism — 4 aim above the price, 6 below, hence their $270 median. “The 1 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 13 ratings (last 6 months)
Strong Buy00%
Buy646%
Hold538%
Sell215%
Strong Sell00%
Go deeper on the analysts
🎯 CME price target all
All 14 calls, one by one, with our verdict on each firm.
→ See all 14 targets, analyst by analyst💡 The best analysts on CME most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in CME? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about CME Group? The JPI assistant answers using our backtest data.
💰 CME Group dividend: yield, history & growth › open the full page
4.87%annual yield
📈 Steady dividend — 6 yrs of consecutive dividend increases
That's ~$11.25 per share per year.
📈 CME Group fundamentals: valuation, margins & growth › open the full page
P/E 23.8Net margin 63.4 %Revenue growth +0.8 %Average P/E
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 53 %
2023
Rev +11%Profit +20%
2024
Rev +10%Profit +9%
2025
Rev +6%Profit +15%
🏛️ CME Group insider buying: who's buying and how much › open the full page
1 insider bought2 buys / 6 mo $515k
🔎 Detailed analyses
🏛️ Which US Congress members hold CME Group (CME)?
7 Congress members have disclosed CME buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Kathy Manning 5× · 43%Donald Beyer 4× · 50%John Curtis 1× · 62%Dean Phillips 1× · 39%Zoe Lofgren 1× · 41%Daniel Goldman 1× · 25%Michael Burgess 1× · 40%
✅ Historical analyst reliability on CME
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Credit Suisse | 100% | +15.0% | 3 |
| Morgan Stanley ↗ | 100% | +12.3% | 2 |
| Wells Fargo ↗ | 100% | +9.2% | 2 |
| Piper Sandler ↗ | 89% | +22.1% | 9 |
| Barclays ↗ | 88% | +11.6% | 8 |
| Jefferies ↗ | 80% | +16.0% | 10 |
| Citigroup ↗ | 76% | +11.6% | 17 |
| UBS ↗ | 75% | +8.1% | 16 |
| Deutsche Bank ↗ | 69% | +12.8% | 29 |
| Oppenheimer ↗ | 64% | +7.6% | 14 |
See the other 9 firms
| Goldman Sachs ↗ | 0% | -26.6% | 3 |
| Rosenblatt ↗ | 11% | -13.3% | 18 |
| JP Morgan ↗ | 27% | -12.4% | 11 |
| Raymond James ↗ | 29% | -9.0% | 7 |
| B of A Securities ↗ | 33% | -3.8% | 6 |
| Keefe, Bruyette & Woods ↗ | 50% | -13.9% | 4 |
| CLSA | 50% | -9.1% | 2 |
| Atlantic Equities | 50% | +4.5% | 2 |
| Argus Research ↗ | 50% | +5.9% | 2 |
📊 What $1,000 invested in CME Group would be worth › open the full page
In short — $1,000 invested in CME Group 10 years ago would be worth $2,437 today, i.e. +9%/yr on average. Best year: 2018 (+29%), worst: 2022 (-26%). Price performance, excluding dividends.
If I'd invested $1,000 in CME Group
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $951 | -5% |
| 3 years ago | $1,313 | +31% |
| 5 years ago | $1,213 | +21% |
Return by year (CME Group)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -19% | $809 (-19%) |
| 2025 | +18% | $951 (-5%) |
| 2024 | +10% | $1,049 (+5%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on CME Group
Loading news…
📋 All analyst calls on CME
Filtered on — · ✕ show all
Deutsche Bank ↗
Aug 19, 26
■ Hold neutral · not a buy · 🎯$270
Price at call : $270.87 — gap to target -0%
Today : $280.94 — gap to target -4%
🎯 on CME : 75% (12 calls matureds) · 📊 on Finance : 42.6% · +1.2% (625 calls)
in progress (365j)
matures : Aug 19, 27
matures : Aug 19, 27
▼ Underweight · 🎯$250
Price at call : $255.31 — upside -2%
Today : $280.94 — upside -11%
🎯 on CME : no call matured yet · 📊 on Finance : 51.9% · -0.5% (505 calls)
in progress (365j)
matures : Jul 23, 27
matures : Jul 23, 27
B of A Securities ↗
Jul 23, 26
▼ Underperform · 🎯$230
Price at call : $255.31 — upside -10%
Today : $280.94 — upside -18%
🎯 on CME : no call matured yet · 📊 on Finance : 51.5% · +4.6% (441 calls)
in progress (365j)
matures : Jul 23, 27
matures : Jul 23, 27
Morgan Stanley ↗
Jul 23, 26
▲ Overweight · 🎯$330
Price at call : $255.31 — upside +29%
Today : $280.94 — upside +17%
🎯 on CME : no call matured yet · 📊 on Finance : 54% · +2.2% (1106 calls)
in progress (365j)
matures : Jul 23, 27
matures : Jul 23, 27
Piper Sandler ↗
Jul 15, 26
▲ Overweight · 🎯$295
Price at call : $245.18 — upside +20%
Today : $280.94 — upside +5%
🎯 on CME : 0% (1 call matured) · 📊 on Finance : 56.7% · +11.1% (413 calls)
in progress (365j)
matures : Jul 15, 27
matures : Jul 15, 27
Morgan Stanley ↗
Jul 10, 26
▲ Overweight · 🎯$324
Price at call : $245.1 — upside +32%
Today : $280.94 — upside +15%
🎯 on CME : no call matured yet · 📊 on Finance : 54% · +2.2% (1106 calls)
in progress (365j)
matures : Jul 10, 27
matures : Jul 10, 27
■ Equal-Weight neutral · not a buy · 🎯$270
Price at call : $239.71 — gap to target +13%
Today : $280.94 — gap to target -4%
🎯 on CME : no call matured yet · 📊 on Finance : 49.8% · +0.4% (959 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
▲ Buy · 🎯$270
Price at call : $243.07 — upside +11%
Today : $280.94 — upside -4%
🎯 on CME : no call matured yet · 📊 on Finance : 39.7% · -6.2% (58 calls)
in progress (365j)
matures : Jul 8, 27
matures : Jul 8, 27
See the other 66 calls, newest to oldest
■ Neutral neutral · not a buy · 🎯$260
Price at call : $234.76 — gap to target +11%
Today : $280.94 — gap to target -7%
🎯 on CME : no call matured yet · 📊 on Finance : 48.1% · +2.5% (482 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
Raymond James ↗
Jul 2, 26
▲ Outperform · 🎯$320
Price at call : $234.76 — upside +36%
Today : $280.94 — upside +14%
🎯 on CME : no call matured yet · 📊 on Finance : 52.4% · +0.3% (471 calls)
in progress (365j)
matures : Jul 2, 27
matures : Jul 2, 27
▲ Buy · 🎯$273
Price at call : $245.2 — upside +11%
Today : $280.94 — upside -3%
🎯 on CME : no call matured yet · 📊 on Finance : 39.7% · -6.2% (58 calls)
in progress (365j)
matures : Jun 22, 27
matures : Jun 22, 27
Keefe, Bruyette & Woods ↗
Jun 18, 26
▲ Outperform · 🎯$305
Price at call : $245.2 — upside +24%
Today : $280.94 — upside +9%
🎯 on CME : no call matured yet · 📊 on Finance : 49.7% · +1.3% (491 calls)
in progress (365j)
matures : Jun 18, 27
matures : Jun 18, 27
Rothschild & Co
Jun 11, 26
▲ Buy · 🎯$323
Price at call : $262.18 — upside +23%
Today : $280.94 — upside +15%
🎯 on CME : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Jun 11, 27
matures : Jun 11, 27
Erste Group
Jun 5, 26
■ Hold neutral · not a buy
🎯 on CME : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Jun 5, 27
matures : Jun 5, 27
Morgan Stanley ↗
Apr 23, 26
▲ Overweight · 🎯$353
Price at call : $285.06 — upside +24%
Today : $280.94 — upside +26%
🎯 on CME : no call matured yet · 📊 on Finance : 54% · +2.2% (1106 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
■ Equal-Weight neutral · not a buy · 🎯$316
Price at call : $285.06 — gap to target +11%
Today : $280.94 — gap to target +12%
🎯 on CME : no call matured yet · 📊 on Finance : 49.8% · +0.4% (959 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
▲ Buy · 🎯$323
Price at call : $285.47 — upside +13%
Today : $280.94 — upside +15%
🎯 on CME : no call matured yet · 📊 on Finance : 39.7% · -6.2% (58 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
Piper Sandler ↗
Apr 15, 26
▲ Overweight · 🎯$329
Price at call : $296.22 — upside +11%
Today : $280.94 — upside +17%
🎯 on CME : 0% (1 call matured) · 📊 on Finance : 56.7% · +11.1% (413 calls)
in progress (365j)
matures : Apr 15, 27
matures : Apr 15, 27
■ Equal-Weight neutral · not a buy · 🎯$343
Price at call : $297.03 — gap to target +15%
Today : $280.94 — gap to target +22%
🎯 on CME : no call matured yet · 📊 on Finance : 49.8% · +0.4% (959 calls)
in progress (365j)
matures : Apr 13, 27
matures : Apr 13, 27
Morgan Stanley ↗
Apr 10, 26
▲ Overweight · 🎯$362
Price at call : $295.3 — upside +23%
Today : $280.94 — upside +29%
🎯 on CME : no call matured yet · 📊 on Finance : 54% · +2.2% (1106 calls)
in progress (365j)
matures : Apr 10, 27
matures : Apr 10, 27
▲ Buy · 🎯$340
Price at call : $298.93 — upside +14%
Today : $280.94 — upside +21%
🎯 on CME : no call matured yet · 📊 on Finance : 39.7% · -6.2% (58 calls)
in progress (365j)
matures : Apr 9, 27
matures : Apr 9, 27
■ Equal-Weight neutral · not a buy · 🎯$344
Price at call : $298.93 — gap to target +15%
Today : $280.94 — gap to target +22%
🎯 on CME : no call matured yet · 📊 on Finance : 49.8% · +0.4% (959 calls)
in progress (365j)
matures : Apr 8, 27
matures : Apr 8, 27
Argus Research ↗
Mar 4, 26
■ Hold neutral · not a buy
🎯 on CME : no call matured yet · 📊 on Finance : 52.4% · +1.9% (124 calls)
in progress (365j)
matures : Mar 4, 27
matures : Mar 4, 27
■ Neutral neutral · not a buy · 🎯$310
Price at call : $302.27 — gap to target +3%
Today : $280.94 — gap to target +10%
🎯 on CME : no call matured yet · 📊 on Finance : 48.1% · +2.5% (482 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
▼ Underweight · 🎯$266
Price at call : $302.27 — upside -12%
Today : $280.94 — upside -5%
🎯 on CME : no call matured yet · 📊 on Finance : 51.9% · -0.5% (505 calls)
in progress (365j)
matures : Feb 5, 27
matures : Feb 5, 27
▲ Buy · 🎯$328
Price at call : $302.27 — upside +9%
Today : $280.94 — upside +17%
🎯 on CME : no call matured yet · 📊 on Finance : 39.7% · -6.2% (58 calls)
in progress (365j)
matures : Feb 5, 27
matures : Feb 5, 27
■ Equal-Weight neutral · not a buy · 🎯$312
Price at call : $302.27 — gap to target +3%
Today : $280.94 — gap to target +11%
🎯 on CME : no call matured yet · 📊 on Finance : 49.8% · +0.4% (959 calls)
in progress (365j)
matures : Feb 5, 27
matures : Feb 5, 27
RBC Capital ↗
Feb 5, 26
■ Sector Perform neutral · not a buy · 🎯$302
Price at call : $302.27 — gap to target -0%
Today : $280.94 — gap to target +7%
🎯 on CME : no call matured yet · 📊 on Finance : 44.5% · -1.2% (476 calls)
in progress (365j)
matures : Feb 5, 27
matures : Feb 5, 27
Morgan Stanley ↗
Feb 5, 26
▲ Overweight · 🎯$340
Price at call : $297.38 — upside +14%
Today : $280.94 — upside +21%
🎯 on CME : no call matured yet · 📊 on Finance : 54% · +2.2% (1106 calls)
in progress (365j)
matures : Feb 5, 27
matures : Feb 5, 27
Morgan Stanley ↗
Jan 15, 26
▲ Overweight · 🎯$319
Price at call : $279.5 — upside +14%
Today : $280.94 — upside +14%
🎯 on CME : no call matured yet · 📊 on Finance : 54% · +2.2% (1106 calls)
in progress (365j)
matures : Jan 15, 27
matures : Jan 15, 27
▲ Buy · 🎯$305
Price at call : $272.59 — upside +12%
Today : $280.94 — upside +9%
🎯 on CME : no call matured yet · 📊 on Finance : 39.7% · -6.2% (58 calls)
in progress (365j)
matures : Jan 14, 27
matures : Jan 14, 27
Morgan Stanley ↗
Dec 22, 25
▲ Overweight · 🎯$320
Price at call : $275.53 — upside +16%
Today : $280.94 — upside +14%
🎯 on CME : no call matured yet · 📊 on Finance : 54% · +2.2% (1106 calls)
in progress (365j)
matures : Dec 22, 26
matures : Dec 22, 26
■ Equal-Weight neutral · not a buy · 🎯$304
Price at call : $272.18 — gap to target +12%
Today : $280.94 — gap to target +8%
🎯 on CME : no call matured yet · 📊 on Finance : 49.8% · +0.4% (959 calls)
in progress (365j)
matures : Dec 12, 26
matures : Dec 12, 26
Piper Sandler ↗
Nov 13, 25
▲ Overweight · 🎯$313
Price at call : $285.04 — upside +10%
Today : $280.94 — upside +11%
🎯 on CME : 0% (1 call matured) · 📊 on Finance : 56.7% · +11.1% (413 calls)
in progress (365j)
matures : Nov 13, 26
matures : Nov 13, 26
■ Neutral neutral · not a buy · 🎯$280
Price at call : $269.54 — gap to target +4%
Today : $280.94 — gap to target -0%
🎯 on CME : no call matured yet · 📊 on Finance : 48.1% · +2.5% (482 calls)
in progress (365j)
matures : Oct 23, 26
matures : Oct 23, 26
Morgan Stanley ↗
Oct 23, 25
▲ Overweight · 🎯$314
Price at call : $269.54 — upside +16%
Today : $280.94 — upside +12%
🎯 on CME : no call matured yet · 📊 on Finance : 54% · +2.2% (1106 calls)
in progress (365j)
matures : Oct 23, 26
matures : Oct 23, 26
Deutsche Bank ↗
Oct 23, 25
▲ Buy · 🎯$300
Price at call : $268.9 — upside +12%
Today : $280.94 — upside +7%
🎯 on CME : 75% (12 calls matureds) · 📊 on Finance : 42.6% · +1.2% (625 calls)
in progress (365j)
matures : Oct 23, 26
matures : Oct 23, 26
Raymond James ↗
Oct 13, 25
▲ Outperform · 🎯$307
Price at call : $267.18 — upside +15%
Today : $280.94 — upside +9%
🎯 on CME : no call matured yet · 📊 on Finance : 52.4% · +0.3% (471 calls)
in progress (365j)
matures : Oct 13, 26
matures : Oct 13, 26
■ Equal-Weight neutral · not a buy · 🎯$280
Price at call : $268.84 — gap to target +4%
Today : $280.94 — gap to target -0%
🎯 on CME : no call matured yet · 📊 on Finance : 49.8% · +0.4% (959 calls)
in progress (365j)
matures : Oct 8, 26
matures : Oct 8, 26
Morgan Stanley ↗
Oct 1, 25
▲ Overweight · 🎯$312
Price at call : $265.43 — upside +18%
Today : $280.94 — upside +11%
🎯 on CME : no call matured yet · 📊 on Finance : 54% · +2.2% (1106 calls)
in progress (365j)
matures : Oct 1, 26
matures : Oct 1, 26
▼ Underweight · 🎯$252
Price at call : $268.73 — upside -6%
Today : $280.94 — upside -10%
🎯 on CME : no call matured yet · 📊 on Finance : 51.9% · -0.5% (505 calls)
in progress (365j)
matures : Sep 25, 26
matures : Sep 25, 26
▲ Buy · 🎯$300
Price at call : $268.73 — upside +12%
Today : $280.94 — upside +7%
🎯 on CME : no call matured yet · 📊 on Finance : 50.9% · -0.1% (638 calls)
in progress (365j)
matures : Sep 25, 26
matures : Sep 25, 26
■ Neutral neutral · not a buy · 🎯$285
Price at call : $262.58 — gap to target +9%
Today : $280.94 — gap to target +1%
🎯 on CME : no call matured yet · 📊 on Finance : 48.1% · +2.5% (482 calls)
in progress (365j)
matures : Sep 8, 26
matures : Sep 8, 26
■ Neutral neutral · not a buy · 🎯$305
Price at call : $279.55 — gap to target +9%
Today : $280.94 — gap to target +9%
🎯 on CME : no call matured yet · 📊 on Finance : 48.1% · +2.5% (482 calls)
in progress (365j)
matures : Jul 24, 26
matures : Jul 24, 26
Oppenheimer ↗
Jul 24, 25
▲ Outperform · 🎯$303
Price at call : $279.55 — upside +8%
Today : $280.94 — upside +8%
Expected +8% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on CME : 0% (2 calls matureds) · 📊 on Finance : 53.1% · +3.2% (441 calls)
-8.6%
stock -9% · XLF +6%
matured Jul 24, 26
■ Equal-Weight neutral · not a buy · 🎯$298
Price at call : $277.18 — gap to target +8%
Today : $280.94 — gap to target +6%
🎯 on CME : no call matured yet · 📊 on Finance : 49.8% · +0.4% (959 calls)
in progress (365j)
matures : Jul 24, 26
matures : Jul 24, 26
Piper Sandler ↗
Jul 15, 25
▲ Overweight · 🎯$296
Price at call : $277.53 — upside +7%
Today : $280.94 — upside +5%
Expected +7% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on CME : 0% (1 call matured) · 📊 on Finance : 56.7% · +11.1% (413 calls)
-11.3%
stock -11% · XLF +9%
matured Jul 15, 26
■ Equal-Weight neutral · not a buy · 🎯$299
Price at call : $275.08 — gap to target +9%
Today : $280.94 — gap to target +6%
🎯 on CME : no call matured yet · 📊 on Finance : 49.8% · +0.4% (959 calls)
in progress (365j)
matures : Jul 10, 26
matures : Jul 10, 26
■ Neutral neutral · not a buy · 🎯$275
Price at call : $276.7 — gap to target -1%
Today : $280.94 — gap to target -2%
🎯 on CME : no call matured yet · 📊 on Finance : 50.9% · -0.1% (638 calls)
in progress (365j)
matures : Jul 3, 26
matures : Jul 3, 26
Oppenheimer ↗
Jun 4, 25
▲ Outperform · 🎯$300
Price at call : $274.9 — upside +9%
Today : $280.94 — upside +7%
Expected +9% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on CME : 0% (2 calls matureds) · 📊 on Finance : 53.1% · +3.2% (441 calls)
-6.4%
stock -6% · XLF +3%
matured Jun 4, 26
Rosenblatt ↗
Apr 25, 24
▼ Sell · 🎯$187
Price at call : $212.54 — upside -12%
Today : $280.94 — upside -33%
Expected -12% · Actual +25% · Reason (≤ −15%) : ✗ No
🎯 on CME : 17% (12 calls matureds) · 📊 on Finance : 46.5% · -5.9% (101 calls)
-25.3%
stock +25% · XLF +17%
matured Apr 25, 25
Rosenblatt ↗
Jan 4, 24
▼ Sell · 🎯$180
Price at call : $202.74 — upside -11%
Today : $280.94 — upside -36%
Expected -11% · Actual +15% · Reason (≤ −15%) : ✗ No
🎯 on CME : 17% (12 calls matureds) · 📊 on Finance : 46.5% · -5.9% (101 calls)
-14.7%
stock +15% · XLF +29%
matured Jan 3, 25
Rosenblatt ↗
Oct 26, 23
▼ Sell · 🎯$180
Price at call : $215.43 — upside -16%
Today : $280.94 — upside -36%
Expected -16% · Actual +5% · Reason (≤ −15%) : ✗ No
🎯 on CME : 17% (12 calls matureds) · 📊 on Finance : 46.5% · -5.9% (101 calls)
-5.0%
stock +5% · XLF +46%
matured Oct 25, 24
Deutsche Bank ↗
Oct 11, 23
▲ Buy · 🎯$240
Price at call : $217.1 — upside +11%
Today : $280.94 — upside -15%
Expected +11% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on CME : 75% (12 calls matureds) · 📊 on Finance : 42.6% · +1.2% (625 calls)
+1.9%
stock +2% · XLF +37%
matured Oct 10, 24
Rosenblatt ↗
Oct 4, 23
▼ Sell · 🎯$173
Price at call : $203.24 — upside -15%
Today : $280.94 — upside -38%
Expected -15% · Actual +10% · Reason (≤ −15%) : ✗ No
🎯 on CME : 17% (12 calls matureds) · 📊 on Finance : 46.5% · -5.9% (101 calls)
-10.3%
stock +10% · XLF +38%
matured Oct 3, 24
Rosenblatt ↗
Jul 27, 23
▼ Sell · 🎯$173
Price at call : $198.66 — upside -13%
Today : $280.94 — upside -38%
Expected -13% · Actual +1% · Reason (≤ −15%) : ✗ No
🎯 on CME : 17% (12 calls matureds) · 📊 on Finance : 46.5% · -5.9% (101 calls)
-0.9%
stock +1% · XLF +24%
matured Jul 26, 24
Rosenblatt ↗
Jul 6, 23
▼ Sell · 🎯$169
Price at call : $183.25 — upside -8%
Today : $280.94 — upside -40%
Expected -8% · Actual +7% · Reason (≤ −15%) : ✗ No
🎯 on CME : 17% (12 calls matureds) · 📊 on Finance : 46.5% · -5.9% (101 calls)
-7.2%
stock +7% · XLF +24%
matured Jul 5, 24
Rosenblatt ↗
Apr 5, 23
▼ Sell · 🎯$161
Price at call : $195.19 — upside -18%
Today : $280.94 — upside -43%
Expected -18% · Actual +9% · Reason (≤ −15%) : ✗ No
🎯 on CME : 17% (12 calls matureds) · 📊 on Finance : 46.5% · -5.9% (101 calls)
-8.7%
stock +9% · XLF +29%
matured Apr 4, 24
Rosenblatt ↗
Feb 9, 23
▼ Sell · 🎯$161
Price at call : $182.92 — upside -12%
Today : $280.94 — upside -43%
Expected -12% · Actual +12% · Reason (≤ −15%) : ✗ No
🎯 on CME : 17% (12 calls matureds) · 📊 on Finance : 46.5% · -5.9% (101 calls)
-12.1%
stock +12% · XLF +7%
matured Feb 9, 24
Deutsche Bank ↗
Oct 12, 22
▲ Buy
Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on CME : 75% (12 calls matureds) · 📊 on Finance : 42.6% · +1.2% (625 calls)
+28.2%
stock +28% · XLF +9%
matured Oct 12, 23
Rosenblatt ↗
Oct 5, 22
▼ Sell · 🎯$161
Price at call : $180.87 — upside -11%
Today : $280.94 — upside -43%
Expected -11% · Actual +15% · Reason (≤ −15%) : ✗ No
🎯 on CME : 17% (12 calls matureds) · 📊 on Finance : 46.5% · -5.9% (101 calls)
-14.7%
stock +15% · XLF +2%
matured Oct 5, 23
Rosenblatt ↗
Aug 17, 22
▼ Sell · 🎯$171
Price at call : $206.45 — upside -17%
Today : $280.94 — upside -39%
Expected -17% · Actual -1% · Reason (≤ −15%) : ✗ No
🎯 on CME : 17% (12 calls matureds) · 📊 on Finance : 46.5% · -5.9% (101 calls)
+1.2%
stock -1% · XLF -5%
matured Aug 17, 23
Rosenblatt ↗
Oct 28, 21
▼ Sell · 🎯$197
Price at call : $218.34 — upside -10%
Today : $280.94 — upside -30%
Expected -10% · Actual -20% · Reason (≤ −15%) : ✓ Yes
🎯 on CME : 17% (12 calls matureds) · 📊 on Finance : 46.5% · -5.9% (101 calls)
+20.0%
stock -20% · XLF -15%
matured Oct 28, 22
Rosenblatt ↗
Jan 6, 21
▼ Sell · 🎯$135
Price at call : $193.38 — upside -30%
Today : $280.94 — upside -52%
Expected -30% · Actual +17% · Reason (≤ −15%) : ✗ No
🎯 on CME : 17% (12 calls matureds) · 📊 on Finance : 46.5% · -5.9% (101 calls)
-16.7%
stock +17% · XLF +33%
matured Jan 6, 22
Deutsche Bank ↗
Oct 29, 20
▲ Buy · 🎯$167
Price at call : $150.72 — upside +11%
Today : $280.94 — upside -41%
Expected +11% · Actual +45% · Reason (≥ +15%) : ✓ Yes
🎯 on CME : 75% (12 calls matureds) · 📊 on Finance : 42.6% · +1.2% (625 calls)
+44.9%
stock +45% · XLF +69%
matured Oct 29, 21
Deutsche Bank ↗
Jul 30, 20
▲ Buy · 🎯$178
Price at call : $163.1 — upside +9%
Today : $280.94 — upside -37%
Expected +9% · Actual +30% · Reason (≥ +15%) : ✓ Yes
🎯 on CME : 75% (12 calls matureds) · 📊 on Finance : 42.6% · +1.2% (625 calls)
+30.1%
stock +30% · XLF +52%
matured Jul 30, 21
Deutsche Bank ↗
Jul 9, 20
▲ Buy · 🎯$196
Price at call : $165.53 — upside +18%
Today : $280.94 — upside -30%
Expected +18% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on CME : 75% (12 calls matureds) · 📊 on Finance : 42.6% · +1.2% (625 calls)
+26.6%
stock +27% · XLF +62%
matured Jul 9, 21
Deutsche Bank ↗
May 15, 20
▲ Buy · 🎯$191
Price at call : $181.07 — upside +5%
Today : $280.94 — upside -32%
Expected +5% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on CME : 75% (12 calls matureds) · 📊 on Finance : 42.6% · +1.2% (625 calls)
+19.5%
stock +20% · XLF +80%
matured May 15, 21
Deutsche Bank ↗
Apr 9, 20
▲ Buy · 🎯$200
Price at call : $182.68 — upside +9%
Today : $280.94 — upside -29%
Expected +9% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on CME : 75% (12 calls matureds) · 📊 on Finance : 42.6% · +1.2% (625 calls)
+12.0%
stock +12% · XLF +57%
matured Apr 9, 21
Deutsche Bank ↗
Mar 31, 20
▲ Buy · 🎯$240
Price at call : $166.2 — upside +44%
Today : $280.94 — upside -15%
Expected +44% · Actual +24% · Reason (≥ +15%) : ✓ Yes
🎯 on CME : 75% (12 calls matureds) · 📊 on Finance : 42.6% · +1.2% (625 calls)
+24.0%
stock +24% · XLF +76%
matured Mar 31, 21
Deutsche Bank ↗
Mar 18, 20
▲ Buy · 🎯$243
Price at call : $142.97 — upside +70%
Today : $280.94 — upside -14%
Expected +70% · Actual +44% · Reason (≥ +15%) : ✓ Yes
🎯 on CME : 75% (12 calls matureds) · 📊 on Finance : 42.6% · +1.2% (625 calls)
+43.9%
stock +44% · XLF +80%
matured Mar 18, 21
Deutsche Bank ↗
Mar 5, 20
▲ Buy · 🎯$260
Price at call : $221.82 — upside +17%
Today : $280.94 — upside -7%
Expected +17% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on CME : 75% (12 calls matureds) · 📊 on Finance : 42.6% · +1.2% (625 calls)
-3.6%
stock -4% · XLF +27%
matured Mar 5, 21
Deutsche Bank ↗
Dec 19, 19
▲ Buy · 🎯$252
Price at call : $204.72 — upside +23%
Today : $280.94 — upside -10%
Expected +23% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on CME : 75% (12 calls matureds) · 📊 on Finance : 42.6% · +1.2% (625 calls)
-10.1%
stock -10% · XLF -8%
matured Dec 18, 20
Deutsche Bank ↗
Nov 27, 19
▲ Buy · 🎯$245
Price at call : $202.73 — upside +21%
Today : $280.94 — upside -13%
Expected +21% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on CME : 75% (12 calls matureds) · 📊 on Finance : 42.6% · +1.2% (625 calls)
-13.8%
stock -14% · XLF -6%
matured Nov 26, 20
Frequently asked questions
Should I buy CME Group stock?
This isn't buy advice. For CME Group, the analyst consensus is "Hold", with an average price target of $270 (-4% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on CME Group). We show the numbers — you decide.
Is it too late to buy CME Group? How high can it go?
The most bullish analyst target on CME Group is $330 (+17% above today's price); the average is $270. That's the upside they see. Check how reliable those analysts have actually been on CME Group on our site before trusting it.
Is CME Group still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 19 analysts have a real record on CME Group, the best hitting 100% over 3 calls. Current consensus: "Hold". Make your call on data, not noise.
Should you invest in CME Group? The case for and against
The arguments for and against, one by one, from the numbers: why invest in CME (and why hesitate).
What has CME Group's past performance been?
Historical returns and a "how much if I had invested" calculator: CME performance & returns.
Does CME Group pay a dividend?
Yield, consistency and growth history of the dividend: CME's dividend.
What is the best month to buy CME?
The 12 months ranked by the stock's past returns: best & worst month to buy CME.
Are insiders buying CME stock?
Executives' and large holders' buys and sells, decoded: insider buying on CME.
PYPL 
V 
AXP 
WFC 
MA 
USB 
SCHW 
GPN